Fig. 5From: The impact of pharmacokinetic gene profiles across human cancersLow expression of drug target genes for administered therapies is associated with patient survival in a mechanism-dependent manner. For specific therapies and per-cancer, examples with at least five patients in each group are shown. Data are presented as in previous figures; N, the number of patients administered the therapy; M, the number of patients with low levels of at least one of the therapy’s targetsBack to article page